AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

STARPHARMA HOLDINGS LTD

0.490

+0.07518.07%

Volume:2.85M

Turnover:1.33M

Market Cap:204.93M

PE:-20.46

High:0.495

Open:0.410

Low:0.410

Close:0.415

52wk High:0.495

52wk Low:0.082

Shares:418.22M

Float Shares:347.84M

Volume Ratio:1.29

T/O Rate:0.82%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.024

EPS(LYR):-0.024

ROE:-42.41%

ROA:-20.06%

PB:10.79

PE(LYR):-20.46

Loading ...

Overview Company News Filings

Company Profile

Company Name:

STARPHARMA HOLDINGS LTD

Exchange:

ASX

Establishment Date:

1997

Employees:

40

Office Location:

4-6 Southampton Crescent,Abbotsford,Victoria,Australia

Website:

http://starpharma.com

Zip Code:

3067

Phone:

Fax:

61 3 9510 5955

Introduction:

Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company focuses on the development of VivaGel, which has completed Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for the prevention of sexually transmitted infections, as well as VivaGel condom, an antiviral condom. It also develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase 1/2 clinical trial, and DEP irinotecan that is in phase 1/2 clinical trials for the treatment of solid tumors. The company was founded in 1996 and is headquartered in Abbotsford, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SPL.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SPL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SPL.AU\",,,,,undefined,":{"symbol":"SPL.AU","market":"AU","secType":"STK","nameCN":"STARPHARMA HOLDINGS LTD","latestPrice":0.49,"timestamp":1770786720000,"preClose":0.415,"halted":0,"volume":2848147,"delay":0,"changeRate":0.1807228915662651,"nameEN":"STARPHARMA HOLDINGS LTD","floatShares":347835291,"shares":418224781,"eps":-0.023946,"marketStatus":"Closed","change":0.075,"latestTime":"02-11 16:12:00 AEDT","open":0.41,"high":0.495,"low":0.41,"amount":1329868,"amplitude":0.204819,"askPrice":0.49,"askSize":81592,"bidPrice":0.455,"bidSize":3500,"shortable":3,"etf":0,"ttmEps":-0.023946,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770850800000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.415,"openAndCloseTimeList":[[1770764400000,1770786000000]],"volumeRatio":1.289925,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SPL.AU\",,,,,undefined,":{"symbol":"SPL.AU","floatShares":347835291,"roa":"-20.06%","roe":"-42.41%","lyrEps":-0.023946,"volumeRatio":1.289925,"shares":418224781,"dividePrice":0,"high":0.495,"amplitude":0.204819,"preClose":0.415,"low":0.41,"week52Low":0.082,"pbRate":"10.79","psRate":"35.03","week52High":0.495,"institutionHeld":0,"latestPrice":0.49,"committee":-0.917736,"eps":-0.023946,"divideRate":0,"volume":2848147,"delay":0,"ttmEps":-0.023946,"open":0.41,"prevYearClose":0.36,"prevWeekClose":0.37,"prevMonthClose":0.38,"prevQuarterClose":0.36,"fiveDayClose":0.41,"twentyDayClose":0.37,"sixtyDayClose":0.415},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPL.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPL.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":4493458,"yearFounded":1997,"employeeNum":40,"address":"4-6 Southampton Crescent,Abbotsford,Victoria,Australia","zipCode":"3067","officePhone":"61 3 8532 2700","officeFax":"61 3 9510 5955"},"stockCompanyDetail":{"websiteUrl":"http://starpharma.com","stockEarnings":[{"period":"1week","weight":-0.0119},{"period":"1month","weight":0.0921},{"period":"3month","weight":-0.0674},{"period":"6month","weight":2.32},{"period":"1year","weight":3.1919},{"period":"ytd","weight":0.1528}],"compareEarnings":[{"period":"1week","weight":-0.0046},{"period":"1month","weight":-0.0033},{"period":"3month","weight":0.0114},{"period":"6month","weight":0.0682},{"period":"1year","weight":0.2023},{"period":"ytd","weight":0.0074}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company focuses on the development of VivaGel, which has completed Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for the prevention of sexually transmitted infections, as well as VivaGel condom, an antiviral condom. It also develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase 1/2 clinical trial, and DEP irinotecan that is in phase 1/2 clinical trials for the treatment of solid tumors. The company was founded in 1996 and is headquartered in Abbotsford, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.01432},{"month":2,"riseRate":0.32,"avgChangeRate":-0.02112},{"month":3,"riseRate":0.36,"avgChangeRate":0.004587},{"month":4,"riseRate":0.32,"avgChangeRate":-0.016831},{"month":5,"riseRate":0.36,"avgChangeRate":-0.041001},{"month":6,"riseRate":0.56,"avgChangeRate":0.039433},{"month":7,"riseRate":0.44,"avgChangeRate":0.004085},{"month":8,"riseRate":0.68,"avgChangeRate":0.099337},{"month":9,"riseRate":0.5,"avgChangeRate":0.017446},{"month":10,"riseRate":0.461538,"avgChangeRate":-0.016585},{"month":11,"riseRate":0.5,"avgChangeRate":0.028409},{"month":12,"riseRate":0.461538,"avgChangeRate":-0.005804}],"exchange":"ASX","name":"STARPHARMA HOLDINGS LTD","nameEN":"STARPHARMA HOLDINGS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SPL.AU\",market:\"AU\",,,undefined,":null}}